AU7316391A - Detection of a characteristic antigen from carcinoma in body fluids - Google Patents

Detection of a characteristic antigen from carcinoma in body fluids

Info

Publication number
AU7316391A
AU7316391A AU73163/91A AU7316391A AU7316391A AU 7316391 A AU7316391 A AU 7316391A AU 73163/91 A AU73163/91 A AU 73163/91A AU 7316391 A AU7316391 A AU 7316391A AU 7316391 A AU7316391 A AU 7316391A
Authority
AU
Australia
Prior art keywords
carcinoma
detection
body fluids
characteristic antigen
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73163/91A
Inventor
Gail M Clinton
Wenhui Hua
Yuzhong J Lin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health Science University
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Publication of AU7316391A publication Critical patent/AU7316391A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
AU73163/91A 1990-01-25 1991-01-25 Detection of a characteristic antigen from carcinoma in body fluids Abandoned AU7316391A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US46976890A 1990-01-25 1990-01-25
US469768 1990-01-25
US64434491A 1991-01-22 1991-01-22
US644344 1991-01-22

Publications (1)

Publication Number Publication Date
AU7316391A true AU7316391A (en) 1991-08-21

Family

ID=27042851

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73163/91A Abandoned AU7316391A (en) 1990-01-25 1991-01-25 Detection of a characteristic antigen from carcinoma in body fluids

Country Status (2)

Country Link
AU (1) AU7316391A (en)
WO (1) WO1991011715A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344760A (en) * 1991-06-03 1994-09-06 Ciba Corning Diagnostics Corp. Method of cancer detection
US7396810B1 (en) 2000-08-14 2008-07-08 Oregon Health Sciences University Compositions and methods for treating cancer by modulating HER-2 and EGF receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803169A (en) * 1986-02-05 1989-02-07 Cetus Corporation Assay for human breast cancer
US4921790A (en) * 1987-04-24 1990-05-01 Research Corporation Tumor specific assay for CA125 ovarian cancer antigen
US4954436A (en) * 1987-08-06 1990-09-04 Trustees Of Dartmouth College Dihydropyridine-sensitive calcium channel as a tumor associated marker
US4946774A (en) * 1987-11-09 1990-08-07 Trustees Of Boston University Process for detecting cancer and for monitoring the effectiveness of cancer therapy

Also Published As

Publication number Publication date
WO1991011715A1 (en) 1991-08-08

Similar Documents

Publication Publication Date Title
AU642745B2 (en) Particle detection
EP0691854A4 (en) Conjugates of proteins and bifunctional ligands
AU3060589A (en) Body fluid drainage device
IL101690A0 (en) Antibodies and methods utilizing the same
AU7319291A (en) Addition of magnetic moieties in fluid bed hydrocarbon processing
AU8326591A (en) Bag valve
AU8465591A (en) Gas and liquid contact body
GB9002856D0 (en) Fluid detection device
AU7762091A (en) Detection of minimal residual disease in lymphoid malignancies
AU6803590A (en) Compartmental body fluid collection tube
GB9324705D0 (en) Flow detection
EP0494413A3 (en) Fluid collection pouch
AU2097592A (en) Fibrinogen-specific monoclonal antibody and uses thereof
AU9028791A (en) Detection and isolation of ligands
AU7680091A (en) Integrated sensor-transducer device and pressure sensor-transducer
EP0491246A3 (en) Volume sensor for fluids
AU5294993A (en) Epidermal surface antigen and uses thereof
EP0673391A4 (en) Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto.
AU7316391A (en) Detection of a characteristic antigen from carcinoma in body fluids
AU3861289A (en) Induced dipole electroviscous fluids
AU3829189A (en) Detecting antigens or antibodies
AU5425194A (en) Detection of anti-hpa antibodies
GB2219598B (en) Functional fluids
GB9023882D0 (en) Surface displacement detection
AU662091B2 (en) Fluid containment bag